Mycosedermyl (Econazole Nitrate)

Mycosedermyl, an imidazole antifungal, is applied topically to manage fungal skin infections.

• Dermatophytosis (tinea corporis, tinea cruris, tinea pedis): reduces fungal growth and alleviates lesion symptoms.
• Cutaneous candidiasis: treats Candida‑related skin infections, promoting resolution of erythema and itching.
• Other superficial fungal skin infections: effective against a broad range of dermatophytes and yeasts, helping clear infection.

• Econazole nitrate inhibits ergosterol synthesis by blocking the fungal cytochrome P450 enzyme lanosterol 14α‑demethylase. This disruption prevents formation of the essential cell‑membrane sterol ergosterol, leading to increased membrane permeability and inhibition of fungal cell growth and replication, producing a fungistatic effect at therapeutic concentrations on susceptible dermatophytes and yeasts.

Topical application of Mycosedermyl may be associated with local adverse reactions.

Common Side Effects

• Burning sensation: a transient feeling of heat or stinging at the site of application, usually resolving within minutes.
• Itching: mild pruritus that may appear shortly after dosing and typically subsides with continued use.
• Redness: localized erythema surrounding the treated area, often mild and temporary.
• Dryness or scaling: mild desquamation or flaking of the skin where the product is applied.

Serious or Rare Side Effects

• Contact dermatitis: an allergic skin reaction characterized by swelling, redness, and vesicle formation that may require discontinuation.
• Severe skin irritation: intense pain, pronounced swelling, or ulceration at the application site, indicating a need for medical evaluation.
• Systemic hypersensitivity: rare anaphylactic‑type reactions such as hives, throat tightness, or difficulty breathing, requiring immediate emergency care.

When using Mycosedermyl, several precautions should be observed to ensure safety and effectiveness.

• Avoid application on broken or inflamed skin: limit use to intact epidermis to reduce irritation risk.
• Do not use on extensive body surface areas: limit treatment to affected sites to minimize systemic absorption.
• Discontinue if allergic reaction occurs: stop application and seek medical advice if signs of dermatitis develop.
• Keep away from eyes, mucous membranes, and genitalia: avoid contact to prevent irritation.
• Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Mycosedermyl may interact with other topical agents or systemic medications that affect fungal metabolism.

Major Interactions (Avoid)

• Concurrent use with other topical antifungals: may increase local irritation without added benefit.
• Systemic azole antifungals (e.g., fluconazole, itraconazole): can potentiate inhibition of cytochrome P450 enzymes, raising risk of systemic toxicity.

Moderate Interactions (Monitor Closely)

• Corticosteroid creams applied to the same area: may mask signs of infection or alter drug absorption.
• Occlusive dressings over treated skin: can enhance drug penetration and increase irritation.
• Herbal or over‑the‑counter skin products containing alcohol or fragrances: may exacerbate local sensitivity.